CHARLES RIVER LABORATORIES INTERNATIONAL, INC. acquires WIL Research
Snapshot
CHARLES RIVER LABORATORIES INTERNATIONAL, INC. acquired WIL Research for approximately $585 million in cash (purchase price $604.8 million including assumed liabilities) in April 2016. The transaction was structured as all cash. WIL Research is a United States (global operations)-based Discovery and Safety Assessment (DSA) business.
- Acquirer
- CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
- Target
- WIL Research
- Value
- approximately $585 million in cash (purchase price $604.8 million including assumed liabilities)
- Date
- April 2016
- Type
- full acquisition
- Status
- ready
The deal at a glance
About this deal
CHARLES RIVER LABORATORIES INTERNATIONAL, INC. acquired WIL Research for approximately $585 million in cash (purchase price $604.8 million including assumed liabilities), a transaction completed in April 2016, structured as all cash.
WIL Research operates in Discovery and Safety Assessment (DSA), is based in United States (global operations). WIL Research was a premier provider of safety assessment and contract development and manufacturing (CDMO) services to biopharmaceutical and agricultural and industrial chemical companies worldwide.
The acquisition enhanced our position as a leading global early-stage CRO by strengthening our ability to partner with clients across the drug discovery and development continuum.
Expected non-GAAP EPS accretion of at least $0.20 in 2016 and $0.45-$0.50 in 2017 Discovery and Safety Assessment (DSA) segment
No advisory firms have been disclosed for this transaction.